These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23089314)

  • 1. Skull base osteomyelitis: current microbiology and management.
    Spielmann PM; Yu R; Neeff M
    J Laryngol Otol; 2013 Jan; 127 Suppl 1():S8-12. PubMed ID: 23089314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report.
    Conde-Díaz C; Llenas-García J; Parra Grande M; Terol Esclapez G; Masiá M; Gutiérrez F
    J Med Case Rep; 2017 Feb; 11(1):48. PubMed ID: 28219414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic osteomyelitis at the base of the skull.
    Hsiao YC; Lee JC; Kang BH; Lin YS
    South Med J; 2006 Oct; 99(10):1121-3. PubMed ID: 17100033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skull base osteomyelitis: incidence of resistance, morbidity, and treatment strategy.
    Le Clerc N; Verillaud B; Duet M; Guichard JP; Herman P; Kania R
    Laryngoscope; 2014 Sep; 124(9):2013-6. PubMed ID: 24752664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic nerve involvement from Pseudomonas aeruginosa -associated skull base osteomyelitis.
    Winter TW; Anwar Z; Lam BL; Schatz NJ; Sternau LL; Guy JR
    JAMA Ophthalmol; 2013 Feb; 131(2):253-5. PubMed ID: 23411899
    [No Abstract]   [Full Text] [Related]  

  • 7. Central skull base osteomyelitis: a rare but life-threatening disease.
    Orioli L; Boute C; Eloy P; De Wispelaere JF; De Coene B; Huang TD; Ausselet N; Delaere B
    Acta Clin Belg; 2015 Aug; 70(4):291-4. PubMed ID: 26284925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skull base osteomyelitis secondary to malignant otitis externa.
    Sreepada GS; Kwartler JA
    Curr Opin Otolaryngol Head Neck Surg; 2003 Oct; 11(5):316-23. PubMed ID: 14502060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotizing external otitis: a report of 46 cases.
    Franco-Vidal V; Blanchet H; Bebear C; Dutronc H; Darrouzet V
    Otol Neurotol; 2007 Sep; 28(6):771-3. PubMed ID: 17721365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skull-base osteomyelitis: fungal vs. bacterial infection.
    Blyth CC; Gomes L; Sorrell TC; da Cruz M; Sud A; Chen SC
    Clin Microbiol Infect; 2011 Feb; 17(2):306-11. PubMed ID: 20384699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masked pseudomonal skull base osteomyelitis presenting with a bilateral Xth cranial nerve palsy.
    Rowlands RG; Lekakis GK; Hinton AE
    J Laryngol Otol; 2002 Jul; 116(7):556-8. PubMed ID: 12238681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant or necrotizing otitis externa: experience in 22 cases].
    Martel J; Duclos JY; Darrouzet V; Guyot M; Bébéar JP
    Ann Otolaryngol Chir Cervicofac; 2000 Nov; 117(5):291. PubMed ID: 11084403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteomyelitis of the skull base due to otologic or sinus infections. 5 cases].
    Bouccara D; Simon-Blancal V; Rodallec M; Cyna-Gorse F; Mosnier I; Fantin B; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 2007 Mar; 124(1):25-32. PubMed ID: 17307132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical presentations of malignant otitis externa.
    Vourexakis Z; Kos MI; Guyot JP
    J Laryngol Otol; 2010 Nov; 124(11):1205-8. PubMed ID: 20193102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of osteomyelitis of the anterior skull base and craniovertebral junction.
    Ducic Y
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):39-42. PubMed ID: 12574757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of culture-negative skull base osteomyelitis.
    Djalilian HR; Shamloo B; Thakkar KH; Najme-Rahim M
    Otol Neurotol; 2006 Feb; 27(2):250-5. PubMed ID: 16436997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa.
    Bernstein JM; Holland NJ; Porter GC; Maw AR
    J Laryngol Otol; 2007 Feb; 121(2):118-23. PubMed ID: 16995959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing external otitis: a case series.
    Soheilipour S; Meidani M; Derakhshandi H; Etemadifar M
    B-ENT; 2013; 9(1):61-6. PubMed ID: 23641593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
    Levenson MJ; Parisier SC; Dolitsky J; Bindra G
    Laryngoscope; 1991 Aug; 101(8):821-4. PubMed ID: 1865729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.